Armata Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Armata Pharmaceuticals, Inc. has filed 1,147 SEC EDGAR filings since 06 Feb 1996

SEC filing history

Showing 76-100 of 694 matching filings.

Per page
25
Current page
4
4

OWNERSHIP DOCUMENT

Filing date
03 Oct 2024
Reporting date
02 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
19 Aug 2024
Reporting date
16 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
28 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-37544

ARS

Filing date
29 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37544

DEF 14A

Filing date
29 Apr 2024
Reporting date
12 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .